-
1دورية
المصدر: Formulary Watch; 11/1/2023, p1-2, 2p
مصطلحات موضوعية: CARDIOVASCULAR disease prevention, DRUG approval, MEDICAL care costs, PHARMACEUTICAL services insurance, HOSPITAL care, SODIUM-glucose cotransporter 2 inhibitors, MEDICAL prescriptions, HEART failure, MEDICARE, INSURANCE
-
2دورية
المؤلفون: Myshko, Denise
المصدر: Formulary Watch; 10/10/2023, p2-2, 1p
مصطلحات موضوعية: CARDIOVASCULAR diseases risk factors, DRUG approval, STATISTICS, LIFE expectancy, DIABETES, PATIENT readmissions, COMPARATIVE studies, HOSPITAL care, COST effectiveness, DISEASE prevalence, DESCRIPTIVE statistics, QUALITY of life, SODIUM-glucose cotransporter 2 inhibitors, MEDICAL prescriptions, DATA analysis, HEART failure, MEDICARE, ADULTS
الشركة/الكيان: UNITED States. Food & Drug Administration
-
3دورية
المصدر: Formulary Watch; 7/13/2023, p3-3, 1p
مصطلحات موضوعية: INTERNET, DRUGSTORES, TYPE 2 diabetes, SODIUM-glucose cotransporter 2 inhibitors
-
4دورية
المؤلفون: Myshko, Denise
المصدر: Formulary Watch; 6/6/2023, p3-3, 1p
مصطلحات موضوعية: DRUG approval, MEDICAL care costs, INVESTIGATIONAL drugs, DIABETES, TREATMENT effectiveness, SODIUM-glucose cotransporter 2 inhibitors, HEART failure
الشركة/الكيان: UNITED States. Food & Drug Administration
-
5دورية
المؤلفون: Blank, Christine
المصدر: Formulary Watch; 5/30/2023, p1-1, 1p
مصطلحات موضوعية: DRUG approval, INVESTIGATIONAL drugs, DRUGS, SODIUM-glucose cotransporter 2 inhibitors, HEART failure
الشركة/الكيان: AMERICAN Heart Association
